T0	Outcomes 23 70	circulating levels of proinflammatory cytokines
T1	Outcomes 394 409	proinflammatory
T2	Outcomes 554 605	circulating levels of the proinflammatory cytokines
T3	Outcomes 1113 1301	Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), soluble tumor necrosis factor-receptor-55 (sTNF-R55), and soluble tumor necrosis factor-receptor-75 (sTNF-R75) concentrations
T4	Outcomes 1550 1590	Clinical, demographic, and cytokine data
T5	Outcomes 1873 1957	primary diagnoses; clinical characteristics; and IL-6, sTNF-R55, and sTNF-R75 levels
T6	Outcomes 2002 2018	TNF-alpha levels
T7	Outcomes 2105 2120	28-day survival
T8	Outcomes 2216 2233	gender difference
T9	Outcomes 2237 2265	survival or cytokine levels.